A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

463

Participants

Timeline

Start Date

December 5, 2016

Primary Completion Date

March 29, 2019

Study Completion Date

January 31, 2027

Conditions
Breast Cancer
Interventions
DRUG

Abemaciclib

Administered orally

DRUG

Anastrozole

Administered orally

DRUG

Letrozole

Administered orally

DRUG

Placebo

Administered orally

DRUG

Fulvestrant

Administered intramuscularly

Trial Locations (45)

2196

The Medical Oncology Centre of Rosebank, Johannesburg

Sandton Oncology Centre, Johannesburg

50035

The Fourth Hospital of Hebei Medical University, Shijiazhuang

100042

Liaoning Cancer Hospital&Institute, Shenyang

100071

The Fifth Medical Center of PLA General Hospital, Beijing

100142

Beijing Cancer Hospital, Beijing

110001

The first affiliated hospital of China medical university, Shenyang

110005

Dr. B. L. Kapur Memorial Hospital, New Delhi

116023

The 2nd Affiliated Hospital of Dalian Medical University, Dalian

130012

Jilin Province Tumor Hospital, Changchun

150081

Harbin Medical University Caner Hospital, Harbin

200032

Fudan University Shanghai Cancer Center, Shanghai

200080

Shanghai General Hospital, Shanghai

210000

Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing

210009

Jiangsu Cancer Hospital, Nanjing

210029

Jiangsu Province Hospital, Nanjing

233004

Afflilated Hospital of Bengbu Medical College, Bengbu

310022

Zhejiang Cancer Hospital, Hangzhou

310052

The Second Affiliate Hospital of Zhejiang University School of medicine, Hangzhou

350014

Fujian Provincial Cancer hospital, Fuzhou

350025

Fuzhou General hospital of Nanjing Military Command, Fuzhou

380016

The Gujarat Cancer & Research Institute (GCRI), Ahmedabad

410013

Hunan Cancer Hospital, Changsha

411001

Jehangir Hospital, Pune

430022

Wuhan Union Hospital Cancer Center, Wuhan

430030

Tongji Hospital Tongji Medical, Science & Technology, Wuhan

430079

Hubei Cancer Hospital, Wuhan

450008

Henan Cancer Hospital, Zhengzhou

510080

Guangdong Province People's Hospital, Guangzhou

510120

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou

530021

Guangxi Medical University Affiliated Tumor Hospital, Nanning

560027

Healthcare Global Enterprises Limited (HCG), Bangalore

560054

M S Ramaiah Medical College Hospitals, Bangalore

632513

Christian Medical College Vellore, Ranipet

700099

Medica Superspecialty Hospital, Kolkata

710061

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

98700 000

ONCOSITE - Centro de Pesquisa Clinica em Oncologia, Ijuí

90110-270

Centro Gaucho Integrado De Oncologia, Hematologia, Ensino E Pesquisa, Porto Alegre

14784-400

Fundação Pio XII - Hospital de Câncer de Barretos, Barretos

15091-000

Hospital de Base de Sao Jose do Rio Preto, São José do Rio Preto

01246-000

Icesp - Instituto Do Câncer Do Estado de São Paulo, São Paulo

01317-000

Clínica de Pesquisa e Centro de Estudos em Ginecologia Oncológica e Mamária LTDA, São Paulo

Unknown

Tianjin Medical University Cancer Institute & Hospital, Tianjin

400 012

Tata Memorial Hospital, Mumbai

0081

Eastleigh Breast Care Center, Pretoria

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY